FDA
approval
· 2020-04-30
FDA Approved: VESTURA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approves Teva's supplemental application for VESTURA, a generic combination oral contraceptive containing drospirenone and ethinyl estradiol.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)